Reuters logo
BRIEF-GSK reports positive results with single-dose tafenoquine in malaria
2017年6月12日 / 上午11点15分 / 5 个月前

BRIEF-GSK reports positive results with single-dose tafenoquine in malaria

June 12 (Reuters) - GlaxoSmithKline Plc

* GSK and MMV announce positive headline Phase III results showing single-dose tafenoquine reduces risk of relapse in patients with Plasmodium vivax malaria Further company coverage: (Reporting by UK bureau)

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below